Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic.
The diversity of 103 clinical isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex obtained between 1991 and 1997 from 17 Czech hospitals was studied by ribotyping, biotyping, plasmid profiling and antibiotic susceptibility testing. According to the EcoRI ribotypes, all but one of these isolates were identified to the DNA group level: 77 isolates were allocated to DNA group 2 (A. baumannii), 14 to DNA group 3, 10 to DNA group 13 sensu Tjernberg and Ursing and one to DNA group 1 (A. calcoaceticus). In total, 50 different EcoRI ribotypes and 10 biotypes were observed. Plasmids were found in 92% of the isolates and a high variability in plasmid profiles was found in isolates of the same DNA group. The combination of typing profiles allowed two predominant groups (termed A and B) to be distinguished among the A. baumannii isolates (37 and eight isolates, respectively) that shared a specific ribotype and were highly similar in other properties. These two groups comprised both sporadic and outbreak isolates and were found in most localities. Group A and B isolates were markedly more resistant to antibiotics than most of the remaining isolates, thus representing 85% of all multiresistant isolates. The features of groups A and B corresponded to those of two epidemic clones identified recently among hospital strains in north-western Europe.
Nemec
A
A
National Institute of Public Health, Srobárova 48, 100 42 Prague 10.
Janda
L
L
Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Melter
O
O
National Institute of Public Health, Srobárova 48, 100 42 Prague 10.
Dijkshoorn
Lenie
L
Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands.
D000151:Acinetobacter Infections / Q000382:microbiology*; D016954:Acinetobacter calcoaceticus / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D018153:Czech Republic; D018432:Drug Resistance, Multiple; D005838:Genotype; D006801:Humans; D008826:Microbial Sensitivity Tests; D010641:Phenotype; D010957:Plasmids / Q000235:genetics; D015183:Restriction Mapping
D000900:Anti-Bacterial Agents